News
LFCR
6.37
+0.16%
0.01
Weekly Report: what happened at LFCR last week (1102-1106)?
Weekly Report · 2d ago
Lifecore Biomedical Receives Antitrust Clearance for Proposed Merger
TipRanks · 6d ago
Analysts Offer Insights on Healthcare Companies: Lifecore Biomedical (LFCR), Addus Homecare (ADUS) and Pfizer (PFE)
TipRanks · 6d ago
Lifecore reports Q3 EPS ($1.08), consensus (30c)
TipRanks · 11/04 13:05
*Lifecore Biomedical 3Q Rev $25.3M >LFCR
Dow Jones · 11/04 12:17
*Lifecore Biomedical 3Q Loss/Shr $1.08 >LFCR
Dow Jones · 11/04 12:17
Press Release: Lifecore Biomedical Reports -2-
Dow Jones · 11/04 12:05
Weekly Report: what happened at LFCR last week (1026-1030)?
Weekly Report · 11/02 10:01
Weekly Report: what happened at LFCR last week (1019-1023)?
Weekly Report · 10/26 10:00
Lifecore Sets Record Date for Merger Vote
TipRanks · 10/20 21:21
Weekly Report: what happened at LFCR last week (1012-1016)?
Weekly Report · 10/19 10:00
Weekly Report: what happened at LFCR last week (1005-1009)?
Weekly Report · 10/12 10:05
Lifecore Biomedical Q2 2026 Earnings Call Transcript
Benzinga · 10/08 08:17
Lifecore Biomedical to Participate at Upcoming Industry Conferences
Barchart · 10/07 15:05
Weekly Report: what happened at LFCR last week (0928-1002)?
Weekly Report · 10/05 10:04
Lifecore Biomedical (LFCR) was downgraded to a Hold Rating at William Blair
TipRanks · 10/05 09:35
Deal Dispatch: Hormel Acquires Brakebush, Onsemi buys Synaptics for $5.7 Billion, Leslie’s Pools Bankruptcy
Benzinga · 10/02 17:35
Lifecore Biomedical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lifecore Biomedical, Inc. - LFCR
Barchart · 09/30 18:05
Lifecore Biomedical Extends Key Manufacturing Pact with Alcon
TipRanks · 09/29 20:30
Wynnefield Capital Discloses About 14.3% Stake In Lifecore Biomedical, Agrees To Vote In Favor Of Its Pending Merger, Per 13D Filing
Benzinga · 09/29 20:18
More
Webull provides a variety of real-time LFCR stock news. You can receive the latest news about Lifecore Biomedical Inc through multiple platforms. This information may help you make smarter investment decisions.
About LFCR
Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization that provides services in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes, vials and cartridges. It manufactures pharmaceutical-grade, non-animal-sourced hyaluronic acid (HA) using fermentation-based HA process. It manufactures HA in bulk form and for use in formulated and filled syringes and vials for our customers’ injectable products used in treating medical conditions and procedures, including ophthalmic and orthopedic applications. Its product development service capabilities include analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation and production of materials for clinical studies. It also operates semi-automated restricted access barrier systems (RABS) and fully automated aseptic filling lines with isolators.